406 related articles for article (PubMed ID: 28485854)
1. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.
Bettaieb A; Koike S; Hsu MF; Ito Y; Chahed S; Bachaalany S; Gruzdev A; Calvo-Rubio M; Lee KSS; Inceoglu B; Imig JD; Villalba JM; Zeldin DC; Hammock BD; Haj FG
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2758-2765. PubMed ID: 28757338
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria.
Hsu MF; Bettaieb A; Ito Y; Graham J; Havel PJ; Haj FG
Sci Rep; 2017 Mar; 7(1):461. PubMed ID: 28352079
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
[TBL] [Abstract][Full Text] [Related]
5. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
7. Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
Bettaieb A; Chahed S; Bachaalany S; Griffey S; Hammock BD; Haj FG
Mol Pharmacol; 2015 Aug; 88(2):281-90. PubMed ID: 25993999
[TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
10. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
[TBL] [Abstract][Full Text] [Related]
11. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
[TBL] [Abstract][Full Text] [Related]
13. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
14. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
Bettaieb A; Nagata N; AbouBechara D; Chahed S; Morisseau C; Hammock BD; Haj FG
J Biol Chem; 2013 May; 288(20):14189-14199. PubMed ID: 23576437
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
Lindfors S; Polianskyte-Prause Z; Bouslama R; Lehtonen E; Mannerla M; Nisen H; Tienari J; Salmenkari H; Forsgård R; Mirtti T; Lehto M; Groop PH; Lehtonen S
Diabetologia; 2021 Aug; 64(8):1866-1879. PubMed ID: 33987714
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice.
Zhang W; Yang AL; Liao J; Li H; Dong H; Chung YT; Bai H; Matkowskyj KA; Hammock BD; Yang GY
Dig Dis Sci; 2012 Oct; 57(10):2580-91. PubMed ID: 22588244
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
20. Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.
Qin X; Wu Q; Lin L; Sun A; Liu S; Li X; Cao X; Gao T; Luo P; Zhu X; Wang X
Mol Neurobiol; 2015 Aug; 52(1):187-95. PubMed ID: 25128026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
